Multiple putative signaling mediators inferred from network pharmacology

The term Multiple putative signaling mediators inferred from network pharmacology does not refer to a single biological molecule or receptor. Instead, it describes a collection of proteins, enzymes, or genes identified through computational systems biology as potential targets for a specific drug or multi-component formulation (Hopkins, 2008). Network pharmacology integrates data from protein-protein interaction databases, gene expression profiles, and chemical structure similarities to map the complex interactions between drugs and biological systems (Zhang et al., 2019). These mediators are typically prioritized based on their connectivity within a disease-related network, such as those involved in inflammation, apoptosis, or cell proliferation. Because these mediators are 'putative,' they represent hypotheses that require experimental validation through assays like Western blotting or qPCR to confirm their role in a specific disease context (Kibble et al., 2015). This grouping is often used to explain the holistic mechanism of action of multi-target therapeutics, particularly in the study of Traditional Chinese Medicine or complex polypharmacology. Consequently, this is a methodological output or a descriptive category rather than a distinct, single therapeutic target.

Multi-target modulation